Diet Matters in Breast Cancer Prognosis: Clinical Trial Evidence and Questions
- PMID: 38117468
- DOI: 10.1158/1078-0432.CCR-23-3195
Diet Matters in Breast Cancer Prognosis: Clinical Trial Evidence and Questions
Abstract
Diet and weight matter in breast cancer prognosis. The DIANA-5 randomized controlled trial found no effect of a Mediterranean macrobiotic diet on 5-year breast cancer recurrence, but high adherence was associated with a 41% lower risk of recurrence versus controls. The effects of substantial weight loss on prognosis remain unknown. See related article by Berrino et al., p. 965.
©2023 American Association for Cancer Research.
Comment on
-
The Effect of Diet on Breast Cancer Recurrence: The DIANA-5 Randomized Trial.Clin Cancer Res. 2024 Mar 1;30(5):965-974. doi: 10.1158/1078-0432.CCR-23-1615. Clin Cancer Res. 2024. PMID: 37847493 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical